REQUEST A DEMO
Total
USD $0.00
Search more companies

Gadalpharma Internacional S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Machinery, Equipment, and Supplies Merchant Wholesalers
Full name: Gadalpharma Internacional S A S Profile Updated: May 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Gadalpharma Internacional S A S is based in Colombia. The head office is in Bogota D.C.. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Gadalpharma Internacional S A S was incorporated on February 20, 2017. There was a net sales revenue drop of 99.85% reported in Gadalpharma Internacional S A S’s latest financial highlights for 2025. During that time, Gadalpharma Internacional S A S’s total assets grew by 61.18%.

Headquarters
Cr 11 A # 117 50 Of 507
Bogota D.C.; Bogota D.C; Postal Code: 1011

Contact Details: Purchase the Gadalpharma Internacional S A S report to view the information.

Website: https://gadalpharma.com/

Basic Information
Financial Auditors:
Purchase the Gadalpharma Internacional S A S report to view the information.
Incorporation Date:
February 20, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Gadalpharma Internacional S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-99.85%
Total Operating Revenue
-99.85%
Operating Profit
-57.38%
Total Assets
61.18%
Total Equity
86.35%
Quick Ratio
4.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?